{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors", "item": "https://www.patentleaderboard.com/patent/6297269"}]}

Home › Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors

Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors

US Patent 6297269 · Granted Oct 2, 2001

Estimated economic value: $475,381,000 ⓘ

Assignee

Pfizer

Inventors

Bernard Hulin (23 patents)
Dennis J. Hoover (17 patents)
Judith Treadway (11 patents)
William H. Martin (27 patents)

View full patent text on Google Patents →